Relation between urinary androgen and corticoid excretion and subsequent breast cancer.
about
Dehydroepiandrosterone inhibits the progression phase of mammary carcinogenesis by inducing cellular senescence via a p16-dependent but p53-independent mechanism.The relationship between sex steroids and bone mineral content in women soon after the menopause.Breast cancer, genetics, and age at first pregnancy.Mechanism of inhibition of growth of 3T3-L1 fibroblasts and their differentiation to adipocytes by dehydroepiandrosterone and related steroids: role of glucose-6-phosphate dehydrogenase.Low serum testosterone concentrations in patients with carcinoma of the pancreasMolecular and cellular basis of the mammary gland susceptibility to carcinogenesisFactors that promote the development of human breast cancer.Endocrine, genetic and viral factors in the etiology of breast cancer.A strategy for the control of endometrial cancer.Plasma retinol, beta-carotene and vitamin E levels in relation to the future risk of breast cancerRatio of 11-desoxy 17-oxosteroids to creatinine in a population screened for breast cancer.Breast cancer: a comparison of response to endocrine therapy and oestrogen excretion patterns including unusual metabolites.Multiple primary cancers of the breast and ovary.Urinary aetiocholanolone in patients with early breast cancer from South East Scotland and South Wales.Concentration of testosterone glucuronide in urine from women with breast tumours.5-En-androstene-3 beta,17 beta-diol inhibits the growth of MCF-7 breast cancer cells when oestrogen receptors are blocked by oestradiol.The role of androgens in hormone replacement therapy.Dehydroepiandrosterone, androgens and the mammary gland.Urinary androgens and breast cancer risk: results from a long-term prospective study based in Guernsey.CAG and GGC repeat polymorphisms in the androgen receptor gene and breast cancer susceptibility in BRCA1/2 carriers and non-carriers.Studies on apparent free cortisol and testosterone in plasma from patients with breast tumours.Hormones are ambiguous risk factors for breast cancer.Hormonal intervention: "buffer hormones" or "state dependency". The role of dehydroepiandrosterone (DHEA), thyroid hormone, estrogen and hypophysectomy in aging.Inhibition of tumor development by dehydroepiandrosterone and related steroids.Sex hormone-binding globulin and the natural history of breast cancer.Adrenal androgen action in breast cancer.Uptake and concentration of steroid hormones in mammary tissues.Vitamin A, dehydroepiandrosterone (DHEA) and 5' nucleotidase: regulatory factors in tumor growth.Effects of dehydroepiandrosterone and other sex steroid hormones on mammary carcinogenesis by direct injection of 7,12-dimethylbenz(a) anthracene (DMBA) in hyperprolactinemic female rats.The epidemiology of cancers of the breast and reproductive system.GRO-alpha in human serum: differences related to age and sex.Dehydroepiandrosterone sulphate (DHEAS) in the oldest old, aged 85 and over.Investigation into the effect of DHEA on renal carcinogenesis induced in the rat by a single dose of DMN.Dehydroepiandrosterone: an anti-obesity and anti-carcinogenic agent.
P2860
Q25257786-AB664A25-1DC9-4D18-9D4C-58DC2491DA5FQ33318817-4FB4EB63-5EBB-401F-9B02-2120B63C64E3Q33671178-F07E1E20-4C37-4E06-A9D9-141AC5F0EE75Q33859257-7C87BEB8-E66E-49A5-B884-F33045882FEBQ34990035-79A3B64D-F2AD-4447-A03E-674707964122Q35037073-776A4361-B0B5-472A-8766-E7D0DBFA0A28Q35037372-2BA718CF-E6BE-4B11-AAA5-AE4EAABFA719Q35142374-2A96E10B-9A48-449B-9F5C-79E5D0B924BEQ35778721-DC5775A5-E283-471B-8AD3-146C35B90EECQ35991449-D556FBA3-DE32-4FB2-820E-1C1B15D13CBDQ36043260-5E524DDA-26DA-4BCE-B652-5F2E9234EB42Q36045750-0CFF4FF1-B9F5-4348-B369-1DB16AD63F3CQ36045797-9D9D54F3-6C1F-4081-B369-A795FCDD3D2EQ36068129-73BD1CE2-7153-4571-BA62-E37F1BD53226Q36069367-2DA141E4-7804-497F-9ED7-4159F8EF473FQ36080636-047C5F8D-E239-48E8-BBC0-7ED5D4BB18A3Q36249910-35B39C7E-B71D-4F34-BC6E-44360E64408CQ36533630-CD61EEE7-1480-4F7A-B898-C57165D2D19BQ36621458-2BD1DE4E-7EF3-4E85-BBFD-56CE9C55C389Q36623059-D897B99A-C95B-4A1D-AB05-65FCBDC491D9Q36714321-DBC7F0B3-FDD3-4DD8-8092-3DD82C102C8CQ38754824-AD9950BD-C8F6-4294-9BDE-010F8ACD58A8Q39486117-911BECD7-0CA0-4437-A151-B602503E08C1Q39505984-A8447FD8-2E95-4EE4-AC9C-6A6296F995C3Q39539975-13A8CBBF-4872-455D-A8A3-9B2F5BF5BBC6Q40999411-8CE88209-F3BF-42D8-9DF4-3A3F6F9B4825Q41353874-22B1FB0B-2565-4BDB-83CA-4B05232D4434Q42017466-3584EF64-4066-446D-9B5B-B144FA2D02E2Q42549865-F0141430-ED1B-4F60-9B48-2FC7C2ACB1C2Q44484108-DC548821-2571-4176-8830-D9CE19B2DA31Q50939770-E93CF43E-9FD4-4EBA-95F5-62648B879D58Q52057957-95C365D1-86CE-4141-841E-6DBC65961ECFQ53511101-3CFCE86A-D752-458F-A395-150C52A4DEC2Q53574301-9381F6F4-DAC7-4AD4-9A74-A2C5D30E5847
P2860
Relation between urinary androgen and corticoid excretion and subsequent breast cancer.
description
1971 nî lūn-bûn
@nan
1971年の論文
@ja
1971年学术文章
@wuu
1971年学术文章
@zh
1971年学术文章
@zh-cn
1971年学术文章
@zh-hans
1971年学术文章
@zh-my
1971年学术文章
@zh-sg
1971年學術文章
@yue
1971年學術文章
@zh-hant
name
Relation between urinary androgen and corticoid excretion and subsequent breast cancer.
@en
Relation between urinary androgen and corticoid excretion and subsequent breast cancer.
@nl
type
label
Relation between urinary androgen and corticoid excretion and subsequent breast cancer.
@en
Relation between urinary androgen and corticoid excretion and subsequent breast cancer.
@nl
prefLabel
Relation between urinary androgen and corticoid excretion and subsequent breast cancer.
@en
Relation between urinary androgen and corticoid excretion and subsequent breast cancer.
@nl
P2093
P1433
P1476
Relation between urinary androgen and corticoid excretion and subsequent breast cancer.
@en
P2093
C C Spicer
J L Hayward
R D Bulbrook
P304
P356
10.1016/S0140-6736(71)90113-9
P407
P577
1971-08-01T00:00:00Z